(2S,5R)-6-(Benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide, 97%, 250mg

4,4',4''-((1,3,5-Triazine-2,4,6-triyl)tris(oxy))trianiline, 97%, 5g

6,8-dibromo-1,2,3,4-tetrahydro-1,5-naphthyridine, 95.0%, 100mg

Difluoroacetic acid, 98.0%, 5g

[2-(isopropylthio)phenyl]amine hydrochloride, 95.0%, 500g

1-Methyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 95.0%, 25g

2-(2-FLUOROPHENYL)-4,5-DIHYDRO-4,4-DIMETHYLOXAZOLE, 95.0%, 250mg

Ethyl 1-Boc-5-oxoazepane-4-carboxylate, 90.0%, 5g

4-Methylpiperidine-4-carbonitrile hydrochloride, 95.0%, 5g

3-Bromothiophene, 97.0%, 25g

Analytical balance HR series Models with internal calibration, 0.0001 g, 252 g, HR-250AZ (W)

Marking tape ROTI®Tape set Core - 25.4 mm, 13.0 mm x 12.7 m, 1 Set

2,4,4,5,5-Pentamethyl-1,3,2-dioxaborolane, 95.0%, 50g